Easy Access and Express Report Delivery Service
Nucleic Acid Therapeutic Market, Global Outlook and Forecast 2023-2029
Report ID
42795
Publisher
Market Monitor Global
Published Date
07-Dec
Delivery Format
PDF
No of Report Page
146
Editor's Rating
-
Report Details
This research report provides a comprehensive analysis of the Nucleic Acid Therapeutic market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Nucleic Acid Therapeutic market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Nucleic Acid Therapeutic, challenges faced by the industry, and potential opportunities for market players. The global Nucleic Acid Therapeutic market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Nucleic Acid Therapeutic market presents opportunities for various stakeholders, including Neuromuscular Diseases, hATTR. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Nucleic Acid Therapeutic market. Additionally, the growing consumer demand present avenues for market expansion. The global Nucleic Acid Therapeutic market was valued at US$ 60320 million in 2022 and is projected to reach US$ 14820 million by 2029, at a CAGR of 3.9% during the forecast period. The Nucleic Acid-Based Therapeutics Drug Market is driven by the promising potential of nucleic acid-based therapies in treating various genetic and acquired diseases, including genetic disorders, cancer, and infectious diseases. These innovative drugs utilize nucleic acids, such as DNA or RNA, to modify or regulate gene expression, correct genetic mutations, or target specific disease-associated genes. As the understanding of genomics and molecular biology advances, and personalized medicine gains traction, the demand for nucleic acid-based therapeutics continues to grow. Innovations in drug development, delivery systems, and gene editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address delivery and stability issues, ensure long-term safety and efficacy, and navigate regulatory complexities and patient acceptance. Overcoming technical and scientific hurdles, optimizing drug delivery methods, and addressing concerns about off-target effects are ongoing challenges. Additionally, the market faces competition from conventional therapies and the need for continuous research and development to unlock the full therapeutic potential of nucleic acid-based drugs. Striking a balance between providing safe, effective, and accessible nucleic acid-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Nucleic Acid-Based Therapeutics Drug Market. Key Features: The research report on the Nucleic Acid Therapeutic market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders. Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Nucleic Acid Therapeutic market. Market Overview: The report provides a comprehensive overview of the Nucleic Acid Therapeutic market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antisense Oligonucleotides (ASO), siRNA), region, and application, highlighting the key drivers, challenges, and opportunities within each segment. Market Dynamics: The report analyses the market dynamics driving the growth and development of the Nucleic Acid Therapeutic market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Nucleic Acid Therapeutic market's trajectory. Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Nucleic Acid Therapeutic market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. Market Segmentation and Forecast: The report segment the Nucleic Acid Therapeutic market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions. Technological Trends: The report should highlight the key technological trends shaping the Nucleic Acid Therapeutic market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences. Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Nucleic Acid Therapeutic market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders. Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Nucleic Acid Therapeutic, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments. Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Nucleic Acid Therapeutic market. Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts. Market Segmentation Nucleic Acid Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value. Market segment by Type Antisense Oligonucleotides (ASO) siRNA mRNA Market segment by Application Neuromuscular Diseases hATTR COVID-19 Other Global Nucleic Acid Therapeutic Market Segment Percentages, By Region and Country, 2022 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Major players covered Sarepta Therapeutics Ionis Pharmaceuticals Alnylam Biogen Nippon Shinyaku Sobi Novartis BioNTech Pfizer Moderna Therapeutics Jazz Pharmaceuticals CureVac Regulus Therapeutics ProQR Secarna MiNA Therapeutics Sylentis Arrowhead Silence Therapeutics Dicerna Outline of Major Chapters: Chapter 1: Introduces the definition of Nucleic Acid Therapeutic, market overview. Chapter 2: Global Nucleic Acid Therapeutic market size in revenue. Chapter 3: Detailed analysis of Nucleic Acid Therapeutic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: Sales of Nucleic Acid Therapeutic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world. Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 8: The main points and conclusions of the report. -
Table Of Content
1 Introduction to Research & Analysis Reports 1.1 Nucleic Acid Therapeutic Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Nucleic Acid Therapeutic Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.3 Base Year 1.5.4 Report Assumptions & Caveats 2 Global Nucleic Acid Therapeutic Overall Market Size 2.1 Global Nucleic Acid Therapeutic Market Size: 2022 VS 2029 2.2 Global Nucleic Acid Therapeutic Market Size, Prospects & Forecasts: 2018-2029 2.3 Key Market Trends, Opportunity, Drivers and Restraints 2.3.1 Market Opportunities & Trends 2.3.2 Market Drivers 2.3.3 Market Restraints 3 Company Landscape 3.1 Top Nucleic Acid Therapeutic Players in Global Market 3.2 Top Global Nucleic Acid Therapeutic Companies Ranked by Revenue 3.3 Global Nucleic Acid Therapeutic Revenue by Companies 3.4 Top 3 and Top 5 Nucleic Acid Therapeutic Companies in Global Market, by Revenue in 2022 3.5 Global Companies Nucleic Acid Therapeutic Product Type 3.6 Tier 1, Tier 2 and Tier 3 Nucleic Acid Therapeutic Players in Global Market 3.6.1 List of Global Tier 1 Nucleic Acid Therapeutic Companies 3.6.2 List of Global Tier 2 and Tier 3 Nucleic Acid Therapeutic Companies 4 Market Sights by Product 4.1 Overview 4.1.1 By Type - Global Nucleic Acid Therapeutic Market Size Markets, 2022 & 2029 4.1.2 Antisense Oligonucleotides (ASO) 4.1.3 siRNA 4.1.4 mRNA 4.2 By Type - Global Nucleic Acid Therapeutic Revenue & Forecasts 4.2.1 By Type - Global Nucleic Acid Therapeutic Revenue, 2018-2023 4.2.2 By Type - Global Nucleic Acid Therapeutic Revenue, 2024-2029 4.2.3 By Type - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029 5 Sights by Application 5.1 Overview 5.1.1 By Application - Global Nucleic Acid Therapeutic Market Size, 2022 & 2029 5.1.2 Neuromuscular Diseases 5.1.3 hATTR 5.1.4 COVID-19 5.1.5 Other 5.2 By Application - Global Nucleic Acid Therapeutic Revenue & Forecasts 5.2.1 By Application - Global Nucleic Acid Therapeutic Revenue, 2018-2023 5.2.2 By Application - Global Nucleic Acid Therapeutic Revenue, 2024-2029 5.2.3 By Application - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029 6 Sights by Region 6.1 By Region - Global Nucleic Acid Therapeutic Market Size, 2022 & 2029 6.2 By Region - Global Nucleic Acid Therapeutic Revenue & Forecasts 6.2.1 By Region - Global Nucleic Acid Therapeutic Revenue, 2018-2023 6.2.2 By Region - Global Nucleic Acid Therapeutic Revenue, 2024-2029 6.2.3 By Region - Global Nucleic Acid Therapeutic Revenue Market Share, 2018-2029 6.3 North America 6.3.1 By Country - North America Nucleic Acid Therapeutic Revenue, 2018-2029 6.3.2 US Nucleic Acid Therapeutic Market Size, 2018-2029 6.3.3 Canada Nucleic Acid Therapeutic Market Size, 2018-2029 6.3.4 Mexico Nucleic Acid Therapeutic Market Size, 2018-2029 6.4 Europe 6.4.1 By Country - Europe Nucleic Acid Therapeutic Revenue, 2018-2029 6.4.2 Germany Nucleic Acid Therapeutic Market Size, 2018-2029 6.4.3 France Nucleic Acid Therapeutic Market Size, 2018-2029 6.4.4 U.K. Nucleic Acid Therapeutic Market Size, 2018-2029 6.4.5 Italy Nucleic Acid Therapeutic Market Size, 2018-2029 6.4.6 Russia Nucleic Acid Therapeutic Market Size, 2018-2029 6.4.7 Nordic Countries Nucleic Acid Therapeutic Market Size, 2018-2029 6.4.8 Benelux Nucleic Acid Therapeutic Market Size, 2018-2029 6.5 Asia 6.5.1 By Region - Asia Nucleic Acid Therapeutic Revenue, 2018-2029 6.5.2 China Nucleic Acid Therapeutic Market Size, 2018-2029 6.5.3 Japan Nucleic Acid Therapeutic Market Size, 2018-2029 6.5.4 South Korea Nucleic Acid Therapeutic Market Size, 2018-2029 6.5.5 Southeast Asia Nucleic Acid Therapeutic Market Size, 2018-2029 6.5.6 India Nucleic Acid Therapeutic Market Size, 2018-2029 6.6 South America 6.6.1 By Country - South America Nucleic Acid Therapeutic Revenue, 2018-2029 6.6.2 Brazil Nucleic Acid Therapeutic Market Size, 2018-2029 6.6.3 Argentina Nucleic Acid Therapeutic Market Size, 2018-2029 6.7 Middle East & Africa 6.7.1 By Country - Middle East & Africa Nucleic Acid Therapeutic Revenue, 2018-2029 6.7.2 Turkey Nucleic Acid Therapeutic Market Size, 2018-2029 6.7.3 Israel Nucleic Acid Therapeutic Market Size, 2018-2029 6.7.4 Saudi Arabia Nucleic Acid Therapeutic Market Size, 2018-2029 6.7.5 UAE Nucleic Acid Therapeutic Market Size, 2018-2029 7 Nucleic Acid Therapeutic Companies Profiles 7.1 Sarepta Therapeutics 7.1.1 Sarepta Therapeutics Company Summary 7.1.2 Sarepta Therapeutics Business Overview 7.1.3 Sarepta Therapeutics Nucleic Acid Therapeutic Major Product Offerings 7.1.4 Sarepta Therapeutics Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.1.5 Sarepta Therapeutics Key News & Latest Developments 7.2 Ionis Pharmaceuticals 7.2.1 Ionis Pharmaceuticals Company Summary 7.2.2 Ionis Pharmaceuticals Business Overview 7.2.3 Ionis Pharmaceuticals Nucleic Acid Therapeutic Major Product Offerings 7.2.4 Ionis Pharmaceuticals Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.2.5 Ionis Pharmaceuticals Key News & Latest Developments 7.3 Alnylam 7.3.1 Alnylam Company Summary 7.3.2 Alnylam Business Overview 7.3.3 Alnylam Nucleic Acid Therapeutic Major Product Offerings 7.3.4 Alnylam Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.3.5 Alnylam Key News & Latest Developments 7.4 Biogen 7.4.1 Biogen Company Summary 7.4.2 Biogen Business Overview 7.4.3 Biogen Nucleic Acid Therapeutic Major Product Offerings 7.4.4 Biogen Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.4.5 Biogen Key News & Latest Developments 7.5 Nippon Shinyaku 7.5.1 Nippon Shinyaku Company Summary 7.5.2 Nippon Shinyaku Business Overview 7.5.3 Nippon Shinyaku Nucleic Acid Therapeutic Major Product Offerings 7.5.4 Nippon Shinyaku Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.5.5 Nippon Shinyaku Key News & Latest Developments 7.6 Sobi 7.6.1 Sobi Company Summary 7.6.2 Sobi Business Overview 7.6.3 Sobi Nucleic Acid Therapeutic Major Product Offerings 7.6.4 Sobi Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.6.5 Sobi Key News & Latest Developments 7.7 Novartis 7.7.1 Novartis Company Summary 7.7.2 Novartis Business Overview 7.7.3 Novartis Nucleic Acid Therapeutic Major Product Offerings 7.7.4 Novartis Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.7.5 Novartis Key News & Latest Developments 7.8 BioNTech 7.8.1 BioNTech Company Summary 7.8.2 BioNTech Business Overview 7.8.3 BioNTech Nucleic Acid Therapeutic Major Product Offerings 7.8.4 BioNTech Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.8.5 BioNTech Key News & Latest Developments 7.9 Pfizer 7.9.1 Pfizer Company Summary 7.9.2 Pfizer Business Overview 7.9.3 Pfizer Nucleic Acid Therapeutic Major Product Offerings 7.9.4 Pfizer Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.9.5 Pfizer Key News & Latest Developments 7.10 Moderna Therapeutics 7.10.1 Moderna Therapeutics Company Summary 7.10.2 Moderna Therapeutics Business Overview 7.10.3 Moderna Therapeutics Nucleic Acid Therapeutic Major Product Offerings 7.10.4 Moderna Therapeutics Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.10.5 Moderna Therapeutics Key News & Latest Developments 7.11 Jazz Pharmaceuticals 7.11.1 Jazz Pharmaceuticals Company Summary 7.11.2 Jazz Pharmaceuticals Business Overview 7.11.3 Jazz Pharmaceuticals Nucleic Acid Therapeutic Major Product Offerings 7.11.4 Jazz Pharmaceuticals Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.11.5 Jazz Pharmaceuticals Key News & Latest Developments 7.12 CureVac 7.12.1 CureVac Company Summary 7.12.2 CureVac Business Overview 7.12.3 CureVac Nucleic Acid Therapeutic Major Product Offerings 7.12.4 CureVac Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.12.5 CureVac Key News & Latest Developments 7.13 Regulus Therapeutics 7.13.1 Regulus Therapeutics Company Summary 7.13.2 Regulus Therapeutics Business Overview 7.13.3 Regulus Therapeutics Nucleic Acid Therapeutic Major Product Offerings 7.13.4 Regulus Therapeutics Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.13.5 Regulus Therapeutics Key News & Latest Developments 7.14 ProQR 7.14.1 ProQR Company Summary 7.14.2 ProQR Business Overview 7.14.3 ProQR Nucleic Acid Therapeutic Major Product Offerings 7.14.4 ProQR Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.14.5 ProQR Key News & Latest Developments 7.15 Secarna 7.15.1 Secarna Company Summary 7.15.2 Secarna Business Overview 7.15.3 Secarna Nucleic Acid Therapeutic Major Product Offerings 7.15.4 Secarna Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.15.5 Secarna Key News & Latest Developments 7.16 MiNA Therapeutics 7.16.1 MiNA Therapeutics Company Summary 7.16.2 MiNA Therapeutics Business Overview 7.16.3 MiNA Therapeutics Nucleic Acid Therapeutic Major Product Offerings 7.16.4 MiNA Therapeutics Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.16.5 MiNA Therapeutics Key News & Latest Developments 7.17 Sylentis 7.17.1 Sylentis Company Summary 7.17.2 Sylentis Business Overview 7.17.3 Sylentis Nucleic Acid Therapeutic Major Product Offerings 7.17.4 Sylentis Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.17.5 Sylentis Key News & Latest Developments 7.18 Arrowhead 7.18.1 Arrowhead Company Summary 7.18.2 Arrowhead Business Overview 7.18.3 Arrowhead Nucleic Acid Therapeutic Major Product Offerings 7.18.4 Arrowhead Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.18.5 Arrowhead Key News & Latest Developments 7.19 Silence Therapeutics 7.19.1 Silence Therapeutics Company Summary 7.19.2 Silence Therapeutics Business Overview 7.19.3 Silence Therapeutics Nucleic Acid Therapeutic Major Product Offerings 7.19.4 Silence Therapeutics Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.19.5 Silence Therapeutics Key News & Latest Developments 7.20 Dicerna 7.20.1 Dicerna Company Summary 7.20.2 Dicerna Business Overview 7.20.3 Dicerna Nucleic Acid Therapeutic Major Product Offerings 7.20.4 Dicerna Nucleic Acid Therapeutic Revenue in Global Market (2018-2023) 7.20.5 Dicerna Key News & Latest Developments 8 Conclusion 9 Appendix 9.1 Note 9.2 Examples of Clients 9.3 Disclaimer -
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
